ENZON PHARMACEUTICALS
About Enzon
Technology Platforms
Research & Development
Marketed Products
Partnering
Newsroom
Investors
Careers
Contact Us


ENZON HEADER PIC
Home > Investors
Analyst Coverage Annual Reports Proxy Materials
Press Releases SEC Filings Request Information Calendar of Events Email Alerts Stock Quote Stock Lookup Corporate Governance Contact Us
Investor Relations
Print Print page     Email Email page

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.'s financial performance into perspective.

Recent Releases

Jan 29, 2010
Enzon Completes Sale of Specialty Pharmaceutical Business

Jan 27, 2010
Enzon Stockholders Approve Sale of Specialty Pharmaceutical Business

View all releases »

 

 

 

Stock Information
(ENZN) NASDAQ
Last Trade 9.000
Change(%) - 0.08
Volume 613,200
Feb 8, 2010 4:00 PM ET
New Product Release
Lab Look
Our four proprietary marketed brands are ABELCET®, ADAGEN®, DEPOCYT®, and ONCASPAR®. To learn more about our recent product releases CLICK HERE
Shareholder Tools
  • Briefcase Shareholder Briefcase
  • Printed Materials Printed Materials
  • Email Alerts Email Alerts
  • Download Center Download Library
  • RSS RSS News Feeds

  • Search Investor Relations


Copyright © 2005-2007 Enzon Pharmaceuticals, Inc. All rights reserved.
Terms of Use
Privacy Information